T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: Differential diagnosis from Hodgkin's lymphoma

Histopathology

Volumn 41, Issue 3, 2002, Pages 216-229

  Fraga, M ^a,d   Garcia Rivero A ^b   Sanchez Verde L ^c   Forteza, J ^a   Piris, M A ^c  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Centro Oncológico M D   (Spain)

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

^d UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Aggressive lymphomas; Differential diagnosis; Histiocyte rich B cell lymphoma; Hodgkin's lymphoma; T cell rich B cell lymphoma

Indexed keywords

CD15 ANTIGEN; CD30 ANTIGEN; CD45 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; PROTEIN BCL 6;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER DIAGNOSIS; CANCER STAGING; CELL PROLIFERATION; CELL SIZE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISSEMINATED CANCER; EPSTEIN BARR VIRUS; FEMALE; GENE REARRANGEMENT; GENETIC ANALYSIS; HISTIOCYTE; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; VIRUS INFECTION;

ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; HISTIOCYTES; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

HUMAN HERPESVIRUS 4;

EID: 0036042896     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2002.01466.x     Document Type: Article

References (42)

1. Diffuse B cell lymphoma with T cell predominance in patients with follicular lymphoma or 'pseudo T cell lymphoma'
2. B-cell lymphomas morphologically resembling T-cell lymphomas
3. T-cell-rich B-cell lymphoma
4. Histiocyte-rich B-cell lymphoma: A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype
5. T-cell-rich B-cell lymphomas. A clinicopathologic study of 19 cases
6. T-cell rich B-cell lymphoma: A morphological variant of a variety of non-Hodgkin's lymphoma or a clinicopathological entity?
7. T-cell-rich B-cell lymphoma. Reflections on changes in hematopathology
8. T-cell rich large B-cell lymphoma. A study of 30 cases, supporting its histologic heterogeneity and lack of clinical distinctiveness
9. T-cell-rich B-cell lymphoma: A clinicopathologic study of eight cases
10. Large B-cell lymphoma rich in T-cells and simulating Hodgkin's disease
11. T-cell rich B-cell non-Hodgkin's lymphoma: A progressed form of follicle centre cell lymphoma and lymphocyte predominance Hodgkin's disease
12. Absence of dendritic reticulum cell staining is helpful for distinguishing T-cell-rich B-cell lymphoma from lymphocyte predominance Hodgkin's disease
13. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
14. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Commitee Meeting-Airlie House, Virginia, November 1997
15. T-cell-rich B-cell lymphoma simulating lymphocyte-rich Hodgkin's disease
16. Differential diagnosis between classic Hodgkin's lymphoma, T-cell-rich B-cell lymphoma and paragranuloma by paraffin immunohistochemistry
17. T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease: Two closely related entities?
18. Bone marrow involvement in T-cell-rich B-cell lymphoma
19. Type 2 Epstein-Barr virus genome and latent membrane protein-1 expression in a T-cell-rich lymphoma of probable B-cell lineage
20. Clonal Epstein-Barr virus genome in T-cell-rich lymphomas of B or probable B lineage
21. T-cell-rich large-B-cell lymphomas contain non-activated CD8+ cytolytic T cells, show increased tumor cell apoptosis, and have lower bcl-2 expression than diffuse large-B-cell lymphomas
22. Expression of CD45RA and CD45RO by nodular lymphocyte predominance Hodgkin's disease and T-cell rich B-cell lymphoma
23. Paraffin section immunohistochemistry II. Hodgkin's disease and large cell anaplastic (Ki1) lymphoma
24. The expression of the B-cell marker mb-1 (CD79a) in Hodgkin's disease
25. Expression of the Ig-associated heterodimer (mg-1 and B29) in Hodgkin's disease
26. Expression of B cell antigens by Hodgkin's and Reed-Sternberg cells in Hodgkin's disease
27. Coexpression of CD15 and CD20 by Reed-Sternberg cells in Hodgkin's disease
28. Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group
29. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma
30. The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease
31. Diffuse lymphocyte-predominant Hodgkin's disease (diffuse paragranuloma). A variant of the B-cell derived nodular type
32. Molecular analysis of single B cells from T-cell-rich B-cell lymphomas shows the derivation of the tumor cells from mutating germinal center B cells and exemplifies means by which immunoglobulin genes are modified in germinal center B cells
33. Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human bcl-6 protein amino-terminal region
34. Lymphocyte predominance Hodgkin's disease: The use of bcl-6 and CD57 in diagnosis and differential diagnosis
35. Bcl-6 protein expression in normal and neoplastic lymphoid tissues
36. CD10 antigen expression correlates with the t(14:18)(q32:q21) major breakpoint region in diffuse large B-cell lymphoma
37. NCL-CD10-270: A new monoclonal antibody recognizing CD10 in paraffin-embedded tissue
38. BCL-6 protein expression in human peripheral T-cell lymphomas is restricted to CD30+ anaplastic large-cell lymphomas
39. Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin's disease represent clonal populations of germinal center-derived tumor B-cells
40. Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells
41. Clonality in nodular lymphocyte-predominant Hodgkin's disease
42. The value of immunophenotyping on paraffin sections in the identification of T-cell rich B-cell lymphomas: Lineage confirmed by JH rearrangement